한빛사논문
Sungyun Cho 1, Yujin Chun 2, Long He 1, Cuauhtemoc B. Ramirez 2,3, Kripa S. Ganesh 4, Kyungjo Jeong 5, Junho Song 5, Jin Gyu Cheong 6, Zhongchi Li 1, Jungmin Choi 5,7, Joohwan Kim 2, Nikos Koundouros 1,8, Fangyuan Ding 9,10, Noah Dephoure 8, Cholsoon Jang 3,10,11, John Blenis 1,8,12, Gina Lee 2,10,11
1Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY, USA
2Department of Microbiology and Molecular Genetics, School of Medicine, University of California Irvine, Irvine, CA, USA
3Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA
4Department of Biochemistry, Weill Cornell Medicine, Cornell University, New York, NY, USA
5Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, South Korea
6Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA
7Department of Genetics, Yale School of Medicine, Yale University, New Haven, CT, USA
8Meyer Cancer Center, Weill Cornell Medicine, Cornell University, New York, NY, USA
9Department of Biomedical Engineering, Department of Developmental and Cell Biology, Department of Pharmaceutical Sciences, Center for Synthetic Biology, and Center for Neural Circuit Mapping, University of California Irvine, Irvine, CA, USA
10Center for Complex Biological Systems and Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA, USA
11Center for Epigenetics and Metabolism, University of California Irvine, Irvine, CA, USA
12Lead contact
Corresponding authors: John Blenis, Gina Lee
Abstract
The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth that stimulates macromolecule synthesis through transcription, RNA processing, and post-translational modification of metabolic enzymes. However, the mechanisms of how mTORC1 orchestrates multiple steps of gene expression programs remain unclear. Here, we identify family with sequence similarity 120A (FAM120A) as a transcription co-activator that couples transcription and splicing of de novo lipid synthesis enzymes downstream of mTORC1-serine/arginine-rich protein kinase 2 (SRPK2) signaling. The mTORC1-activated SRPK2 phosphorylates splicing factor serine/arginine-rich splicing factor 1 (SRSF1), enhancing its binding to FAM120A. FAM120A directly interacts with a lipogenic transcription factor SREBP1 at active promoters, thereby bridging the newly transcribed lipogenic genes from RNA polymerase II to the SRSF1 and U1-70K-containing RNA-splicing machinery. This mTORC1-regulated, multi-protein complex promotes efficient splicing and stability of lipogenic transcripts, resulting in fatty acid synthesis and cancer cell proliferation. These results elucidate FAM120A as a critical transcription co-factor that connects mTORC1-dependent gene regulation programs for anabolic cell growth.
논문정보
관련 링크
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기